FI880716A - Förfarande för framställning av terapeutiskt användbara arylpiperazinylalkylenfenylsubstituerade heterocykliska föreningar - Google Patents

Förfarande för framställning av terapeutiskt användbara arylpiperazinylalkylenfenylsubstituerade heterocykliska föreningar Download PDF

Info

Publication number
FI880716A
FI880716A FI880716A FI880716A FI880716A FI 880716 A FI880716 A FI 880716A FI 880716 A FI880716 A FI 880716A FI 880716 A FI880716 A FI 880716A FI 880716 A FI880716 A FI 880716A
Authority
FI
Finland
Prior art keywords
arylpiperazinylalkylene
preparation
phenyl substituted
substituted heterocyclic
heterocyclic compounds
Prior art date
Application number
FI880716A
Other languages
English (en)
Finnish (fi)
Other versions
FI880716A0 (sv
FI91752C (sv
FI91752B (sv
Inventor
Iii John Adams Lowe
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI880716A0 publication Critical patent/FI880716A0/sv
Publication of FI880716A publication Critical patent/FI880716A/sv
Application granted granted Critical
Publication of FI91752B publication Critical patent/FI91752B/sv
Publication of FI91752C publication Critical patent/FI91752C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/40Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI880716A 1987-02-17 1988-02-16 Förfarande för framställning av terapeutiskt användbara arylpiperazinylalkylenfenylsubstituerade heterocykliska föreningar FI91752C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8700340 1987-02-17
US8700340 1987-02-17

Publications (4)

Publication Number Publication Date
FI880716A0 FI880716A0 (sv) 1988-02-16
FI880716A true FI880716A (sv) 1988-08-18
FI91752B FI91752B (sv) 1994-04-29
FI91752C FI91752C (sv) 1994-08-10

Family

ID=22202287

Family Applications (1)

Application Number Title Priority Date Filing Date
FI880716A FI91752C (sv) 1987-02-17 1988-02-16 Förfarande för framställning av terapeutiskt användbara arylpiperazinylalkylenfenylsubstituerade heterocykliska föreningar

Country Status (30)

Country Link
EP (1) EP0279598B1 (sv)
JP (1) JPH0699405B2 (sv)
KR (1) KR900004126B1 (sv)
CN (1) CN1015627B (sv)
AP (1) AP88A (sv)
AR (1) AR245125A1 (sv)
AT (1) ATE94537T1 (sv)
AU (1) AU583761B2 (sv)
CA (1) CA1312080C (sv)
CS (1) CS272783B2 (sv)
DD (1) DD272080A5 (sv)
DE (1) DE3884007T2 (sv)
DK (1) DK170878B1 (sv)
EG (1) EG18635A (sv)
ES (1) ES2058249T3 (sv)
FI (1) FI91752C (sv)
HU (1) HU207731B (sv)
IE (1) IE61258B1 (sv)
IL (1) IL85368A0 (sv)
IN (1) IN171858B (sv)
MA (1) MA21183A1 (sv)
MX (1) MX174210B (sv)
MY (1) MY103210A (sv)
NO (1) NO170582C (sv)
NZ (1) NZ223530A (sv)
PL (1) PL157118B1 (sv)
PT (1) PT86766B (sv)
SU (1) SU1634136A3 (sv)
YU (1) YU46624B (sv)
ZA (1) ZA881064B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
US5162321A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie 1-naphthyl piperazines useful as 5-HT1A receptor ligands
US5166156A (en) * 1989-12-20 1992-11-24 Adir Et Compagnie Naphthyl piperazines useful as 5-HT1A receptor ligands
FR2655988B1 (fr) * 1989-12-20 1994-05-20 Adir Cie Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5162324A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie Naphyl piperazines useful as 5-HT1A receptor ligands
US5166157A (en) * 1989-12-20 1992-11-24 Adir Et Compagnie Naphthyl piperazines useful as 5-HT1A receptor ligands
PT833820E (pt) * 1995-06-06 2001-07-31 Aventis Pharmaceuticals Inc Av Derivados de benzisoxazol e indazol uteis como agentes antipsicoticos
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
US6288091B1 (en) 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
DK0871619T3 (da) * 1995-12-29 2003-03-03 Boehringer Ingelheim Pharma Phenylthiazolderivater med antiherpesvirusegenskaber
WO1999001420A1 (fr) 1997-07-03 1999-01-14 Taito Co., Ltd. Procede de preparation de derives d'acide 2-aminomalonique, et intermediaires utilises dans ce procede
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2927924A (en) * 1958-04-03 1960-03-08 Lilly Co Eli Novel phenethyl-substituted piperazines
GB948766A (en) * 1959-10-20 1964-02-05 May & Baker Ltd Trifluoromethylphenylpiperazine derivatives
DE1695410A1 (de) * 1967-04-20 1971-04-08 Merck Patent Gmbh Verfahren zur Herstellung von 1-(Thiazolyl-5-alkyl)-4-(pyridyl-2)-piperazinen
JPS5910675B2 (ja) * 1976-03-22 1984-03-10 ウェルファイド株式会社 アラルキルアミン誘導体
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4619930A (en) * 1985-01-16 1986-10-28 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
JPH075579B2 (ja) * 1986-09-01 1995-01-25 吉富製薬株式会社 アミノチアゾ−ル化合物

Also Published As

Publication number Publication date
CA1312080C (en) 1992-12-29
IE61258B1 (en) 1994-10-19
NO880667L (no) 1988-08-18
IL85368A0 (en) 1988-07-31
DE3884007T2 (de) 1994-01-20
KR900004126B1 (ko) 1990-06-16
MA21183A1 (fr) 1988-10-01
AU583761B2 (en) 1989-05-04
MX174210B (es) 1994-04-28
IN171858B (sv) 1993-01-23
AP88A (en) 1990-06-06
YU30388A (en) 1989-10-31
EP0279598A3 (en) 1989-07-26
EP0279598A2 (en) 1988-08-24
PL270653A1 (en) 1988-12-08
HUT50334A (en) 1990-01-29
AP8800082A0 (en) 1988-02-01
PL157118B1 (pl) 1992-04-30
YU46624B (sh) 1994-01-20
DK78888D0 (da) 1988-02-16
DE3884007D1 (de) 1993-10-21
ZA881064B (en) 1989-09-27
AR245125A1 (es) 1993-12-30
JPS63216875A (ja) 1988-09-09
ES2058249T3 (es) 1994-11-01
NO170582C (no) 1992-11-04
MY103210A (en) 1993-05-29
CN88100986A (zh) 1988-09-21
PT86766B (pt) 1992-05-29
DD272080A5 (de) 1989-09-27
FI880716A0 (sv) 1988-02-16
FI91752C (sv) 1994-08-10
JPH0699405B2 (ja) 1994-12-07
DK78888A (da) 1988-08-18
CS96488A2 (en) 1990-04-11
EG18635A (en) 1994-04-30
KR880009964A (ko) 1988-10-06
AU1174088A (en) 1988-08-18
MX10428A (es) 1993-09-01
ATE94537T1 (de) 1993-10-15
IE880420L (en) 1988-08-17
NO880667D0 (no) 1988-02-16
SU1634136A3 (ru) 1991-03-07
HU207731B (en) 1993-05-28
DK170878B1 (da) 1996-02-26
CS272783B2 (en) 1991-02-12
PT86766A (pt) 1988-03-01
NO170582B (no) 1992-07-27
CN1015627B (zh) 1992-02-26
FI91752B (sv) 1994-04-29
NZ223530A (en) 1990-07-26
EP0279598B1 (en) 1993-09-15

Similar Documents

Publication Publication Date Title
FI883064A (sv) Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar
FI880941A (sv) Förfarande för framställning av terapeutiskt användbara piperazinyl-heterocykliska föreningar
FI905941A0 (sv) Förfarande för framställning av terapeutiskt användbara heterocykliska 2-acylaminotiazolderivat
FI882007A (sv) Förfarande för framställning av inhibitorer för steroid-5- -reduktas
FI881223A0 (sv) Förfarande för framställning av terapeutiskt aktiva 9-aminotetrahydroakridiner och därmed närbesläktade föreningar
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
FI94752C (sv) Förfarande för framställning av terapeutiskt användbara propenonoximetrar
FI896249A0 (sv) Förfarande för framställning av terapeutiskt användbara 7-oxabicykloheptylsubstituerade heterocykliska amidprostaglandinderivat
FI881064A0 (sv) Förfarande för framställning av antiinflammatoriska eller analgetiska -aminoetylsubstituerade fenylföreningar
FI880716A (sv) Förfarande för framställning av terapeutiskt användbara arylpiperazinylalkylenfenylsubstituerade heterocykliska föreningar
FI883997A0 (sv) Förfarande för framställning av terapeutiskt användbara substituerade 2-fenyl-4-kinolinkarboxylsyror
FI93215C (sv) Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat
FI880467A0 (sv) Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner
NO168305C (no) Heterocykliske forbindelser
FI884471A0 (sv) Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar
FI893936A0 (sv) Förfarande för framställning av terapeutiskt aktiva föreningar samt mellanprodukter
DK64788A (da) Heterocycliske forbindelser
PT88545A (pt) Process for the manufacture of benzimidazoline-2-oxo-1-carboxylic acid derivative compounds
FI911701A0 (sv) Förfarande för framställning av terapeutiskt användbara 2-substituerade-3-karboxikarbapenemer
FI92188C (sv) Förfarande för framställning av terapeutiskt användbara fenoxialkylpyrokatekolderivat
PT87643A (pt) Process for the preparation of pyran compounds
FI91069B (sv) Förfarande för framställning av 5-C-hydroximetylaldohexosbaserade föreningar
FI882836A (sv) Förfarande för framställning av terapeutiskt användbar (E)-2-(p-fluorfenetyl)-3-fluorallylamin
FI914874A (sv) Förfarande för framställning av nya terapeutiskt användbara C-3-ditioasetalsubstituerade karbapenemföreningar
DK429588D0 (da) Heterocykliske forbindelser

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: PFIZER INC.